Delivery Order SPE2DB24D2100-SPE2DB25FBFCE
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,007.02, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. The contract does not have a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has a ceiling value of $4,099.20 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 30, 2024. The contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,964.49 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid and alcohol dependence. The contract has an ultimate completion date of March 28, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,002.34 Firm Fixed Price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. This order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $26,827.23 Firm Fixed Price Delivery Order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has a May 16, 2025 ultimate completion date. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,475.54 firm fixed-price delivery order contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of alcohol and opioid dependence. The contract has an ultimate completion date of January 23, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,578.10, is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,015.21 fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The award is not designated under any set-aside program and has an ultimate completion date of March 21, 2025....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,828.64 Firm Fixed Price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used in the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,657.24 firm-fixed-price delivery order contract is for the supply of VIVITROL 380 mg vials and diluents, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of July 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFCEDelivery Order
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,104.47 firm fixed-price delivery order is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication used for the treatment of opioid dependence and alcohol dependence. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is not designated as a set-aside contract. The company also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This larger contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 7/8/25 |